Mexico Medical Cannabis Market Size, Share & Trends Analysis Report By Product (Flowers, Oil & Tinctures), By Application (Cancer, Chronic Pain, Depression & Anxiety, Arthritis), And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1 Methodology and Scope
1.1 Research Methodology
1.2 Research Scope and Assumptions
1.3 List to Data Sources
Chapter 2 Executive Summary
2.1 Market Outlook
第三章墨西哥医疗大麻市场变量, Trends & Scope
3.1 Market Segmentation
3.2 Mexico Medical Cannabis Market Dynamics
3.2.1 Market Driver Analysis
3.2.2 Market Restraint Analysis
3.3 Penetration & Growth Prospects Mapping
3.4 Mexico Medical Cannabis Market Analysis Tools
3.4.1 Mexico Medical Cannabis Market - PESTLE Analysis
3.4.1.1 Political & Legal Landscape
3.4.1.2 Environmental Landscape
3.4.1.3 Social Landscape
3.4.1.4 Technology Landscape
3.4.2 Industry Analysis - Porter’s
3.4.2.1 Supplier Power: Moderate
3.4.2.2 Buyer Power: Low
3.4.2.3 Substitution Threat: Low
3.4.2.4 Threat from New Entrants: Moderate
3.4.2.5 Competitive Rivalry: Moderately High
3.4.3 Regulatory Scenario
3.4.4 Mexico Cannabis Business Trends
3.4.5 Opportunity Analysis
Chapter 4 Mexico Medical Cannabis Market: Product Type Estimates & Trend Analysis
4.1 Mexico Medical Cannabis Market: Product Type Movement Analysis
4.2 Flower
4.2.1 Flower Market Estimates and Forecasts, 2017 - 2030 (USD Million)
4.3 Oil and Tinctures
4.3.1 Oils & Tinctures Market Estimates and Forecasts, 2017 - 2030 (USD Million)
Chapter 5 Mexico Medical Cannabis Market: Application Estimates & Trend Analysis
5.1 Mexico Medical Cannabis Market: Application Movement Analysis
5.2 Cancer
5.2.1 Cancer Market Estimates and Forecasts, 2017 - 2030 (USD Million)
5.3 Chronic Pain
5.3.1 Chronic Pain Market Estimates and Forecasts, 2017 - 2030 (USD Million)
5.4 Depression & Anxiety
5.4.1 Depression & Anxiety Market Estimates and Forecasts, 2017 - 2030 (USD Million)
5.5 Arthritis
5.5.1 Arthritis Market Estimates and Forecasts, 2017 - 2030 (USD Million)
5.6 Diabetes
5.6.1 Diabetes Market Estimates and Forecasts, 2017 - 2030 (USD Million)
5.7 Glaucoma
5.7.1 Glaucoma Market Estimates and Forecasts, 2017 - 2030 (USD Million)
5.8 Migraines
5.8.1 Migraines Market Estimates and Forecasts, 2017 - 2030 (USD Million)
5.9 Epilepsy
5.9.1 Epilepsy Market Estimates and Forecasts, 2017 - 2030 (USD Million)
5.10 Multiple Sclerosis
5.10.1 Multiple Sclerosis Market Estimates and Forecasts, 2017 - 2030 (USD Million)
5.11 AIDS
5.11.1 AIDS Market Estimates and Forecasts, 2017 - 2030 (USD Million)
5.12 Amyotrophic Lateral Sclerosis
5.12.1 Amyotrophic Lateral Sclerosis Market Estimates and Forecasts, 2017 - 2030 (USD Million)
5.13 Alzheimer’s Disease
5.13.1 Alzheimer’s Disease Market Estimates and Forecasts, 2017 - 2030 (USD Million)
5.14 Post-Traumatic Stress Disorder
5.14.1 Post-Traumatic Stress Disorder Market Estimates and Forecasts, 2017 - 2030 (USD Million)
5.15 Parkinson’s Disease
5.15.1 Parkinson’s Disease Market Estimates and Forecasts, 2017 - 2030 (USD Million)
5.16 Tourette’s Syndrome
5.16.1 Tourette’s Syndrome Market Estimates and Forecasts, 2017 - 2030 (USD Million)
5.17 Others
5.17.1 Others Market Estimates and Forecasts, 2017 - 2030 (USD Million)
Chapter 6 Competitive Landscape
6.1 Company Profiles
6.1.1 Aurora Cannabis
6.1.1.1 Company overview
6.1.1.2 Financial performance
6.1.1.3 Strategic initiatives
6.1.2 GW Pharmaceuticals, plc.
6.1.2.1 Company overview
6.1.2.2 Financial performance
6.1.2.3 Strategic Initiatives
6.1.3 CANOPY GROWTH CORPORATION
6.1.3.1 Company overview
6.1.3.2 Financial performance
6.1.3.3 Strategic Initiatives
6.1.4 HempMeds
6.1.4.1 Company overview
6.1.4.2 Strategic Initiatives
6.1.5 CV Sciences, Inc.
6.1.5.1 Company overview
6.1.5.2 Strategic Initiatives
6.1.6 ENDOCA
6.1.6.1 Company overview
6.1.7 Isodiol International Inc.
6.1.7.1 Company overview
6.1.7.2 Strategic Initiatives
6.1.8 CBD Life
6.1.8.1 Company overview
6.1.8.2 Strategic initiatives
6.1.9 PharmaCielo.com
6.1.9.1 Company overview
6.1.9.2 Strategic initiatives
6.1.10 CBD American Shaman
6.1.10.1 Company overview
6.1.11 Elixinol
6.1.11.1 Company overview
6.1.12 Jazz Pharmaceuticals, Inc
6.1.12.1 Company overview
6.1.12.2 Strategic initiatives

List of Figures

Fig. 1 Mexico medical cannabis market snapshot, 2021 (USD Million)
Fig. 2 Mexico medical cannabis market segmentation
Fig. 3 Mexico medical cannabis market dynamics
Fig. 4 Mexico medical cannabis market driver impact
Fig. 5 Mexico medical cannabis market restraints impact
Fig. 6 Penetration & growth prospects mapping for medical cannabis
Fig. 7 Mexico medical cannabis market: Opportunity analysis
Fig. 8 Mexico medical cannabis market, Product type outlook: Key takeaways
Fig. 9 Mexico medical cannabis market: Product movement analysis (2021 & 2030) (USD Million)
Fig. 10 Flower market estimates and forecasts, 2017 - 2030 (USD Million)
Fig. 11 Oils & Tinctures market estimates and forecasts, 2017 - 2030 (USD Million)
Fig. 12 Mexico medical cannabis market, application outlook: Key takeaways
Fig. 13 Mexico medical cannabis market: application movement analysis (2021 & 2030)
Fig. 14 Cancer market estimates and forecasts, 2017 - 2030 (USD Million)
Fig. 15 Chronic pain market estimates and forecasts, 2017 - 2030 (USD Million)
Fig. 16 Depression & Anxiety market estimates and forecasts, 2017 - 2030 (USD Million)
Fig. 17 Arthritis market estimates and forecasts, 2017 - 2030 (USD Million)
Fig. 18 Diabetes market estimates and forecasts, 2017 - 2030 (USD Million)
Fig. 19 Glaucoma market estimates and forecasts, 2017 - 2030 (USD Million)
Fig. 20 Migraines market estimates and forecasts, 2017 - 2030 (USD Million)
Fig. 21 Epilepsy market estimates and forecasts, 2017 - 2030 (USD Million)
Fig. 22 Multiple Sclerosis market estimates and forecasts, 2017 - 2030 (USD Million)
Fig. 23 AIDS market estimates and forecasts, 2017 - 2030 (USD Million)
Fig. 24 Amyotrophic Lateral Sclerosis market estimates and forecasts, 2017 - 2030 (USD Million)
Fig. 25 Alzheimer’s Disease market estimates and forecasts, 2017 - 2030 (USD Million)
Fig. 26 Post-Traumatic Stress Disorder market estimates and forecasts, 2017 - 2030 (USD Million)
Fig. 27 Parkinson’s Disease market estimates and forecasts, 2017 - 2030 (USD Million)
Fig. 28 Tourette’s Syndrome market estimates and forecasts, 2017 - 2030 (USD Million)
Fig. 29 Other market estimates and forecasts, 2017 - 2030 (USD Million)